In this population-based cohort study, maternal-newborn ABO blood group incongruence was not associated with a lower risk of bacterial infection within 30 days of birth (primary outcome) or within 7 days of birth (secondary outcome). This evidence concerns the gene ABO and bacterial infectious disease.